4-ethyl-2-methyl-4-nitrodecahydropyrido[1,2-a][1,4]diazepine(56434-43-6)
- Name: 4-ethyl-2-methyl-4-nitrodecahydropyrido[1,2-a][1,4]diazepine
- Synonyms:Pyrido[1,2-a][1,4]diazepine,4-ethyldecahydro-2-methyl-4-nitro-, dihydrochloride (9CI); NSC 293787
- Molecular Formula:C12H23 N3 O2 . 2 Cl H
- Molecular Weight:241.3299
- CAS Registry Number:56434-43-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.56434-43-6 Pyrido[1,2-a][1,4]diazepine,4-ethyldecahydro-2-methyl-4-nitro-, hydrochloride (1:2)
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]

Other Product
- 68758-76-9/2-Propenoic acid, polymer with 2-propenoic acid, butyl ester, 2-propenoic acid, 2-hydroxyethyl ester and 2-propenoic acid, isooctyl ester
- 26377-76-4/2-1H-indol-3-ylisothiourea, monohydroiodide
- 66234-57-9/7-(benzylamino)-3-methyl-6-nitroquinazolin-4(3H)-one
- 94023-71-9/[(2-carboxyethoxy)methyl]dimethylsulphonium bromide
- 24184-43-8/methyl D-serinate
- 66225-64-7/Cuprate(4-), [m-[[2,2'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)(2-oxido-2,1-diazenediyl)[1-(hydroxy-kO)-3-sulfo-7,2-naphthalenediyl]-2,1-diazenediyl-kN1]]bis[benzoato-kO]](8-)]]di-, sodium (1:4)
- 90053-70-6/1-methyl-4-[(4E,8E,12E)-5,9,13,17-tetramethyloctadeca-4,8,12,16-tetraenoyl]piperazine
- 204330-93-8/Propanoic acid,2,2-dimethyl-,2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(phenylmethyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethylester
- 85117-44-8/Benzene,mono-C10-14-alkyl derivs., fractionation bottoms, hydrogenated
- 4342-09-0/(4Z)-4-(3,3-dibutyltriazanylidene)-4H-imidazole-5-carboxamide
- 6341-74-8/1-{[2-(methylideneamino)naphthalen-1-yl]methyl}naphthalen-2-ol
- 98705-47-6/4,5alpha-Epoxy-6alpha-hydroxy-17-methyl-3-(2-morpholinioethoxy)morphinan bis(4-hydroxy-3-methoxybenzenesulphonate)
- 9003-33-2/POLY(VINYL FORMAL)
- 94334-37-9/Brain, medullaoblongata, ext.
- 30855-79-9/1-(4-nitrophenyl)aziridine
- 82921-32-2/6-amino-2-(dicyanomethylidene)-4-(4-methoxyphenyl)-1,2-dihydropyridine-3,5-dicarbonitrile
- 106424-71-9/Benzenesulfonic acid, 3,3'-(1,2,3,8,9,10-hexahydro- 1,3,8,10-tetraoxoanthra[2,1,9-def:6,5,10-d'e'f' ]diisoquinoline-2,9-diyl)bis[6-[(-amino-6-chlor o-8-triazin-2-yl)amino]-, disodium salt
- 59794-34-2/3(2H)-Benzothiazoleaceticacid, 2-thioxo-
- 86247-90-7/17-hydroxy-3,11,20-trioxopregn-4-en-21-yl hexanoate
- 56434-43-6/4-ethyl-2-methyl-4-nitrodecahydropyrido[1,2-a][1,4]diazepine
- 5432-17-7/ETHYL M-ETHOXYBENZOATE
- 80238-38-6/(2-acetylhydrazinylidene)(phenyl)acetic acid
- 90888-87-2/Tetracyclo[4.3.1.03,10.08,10]decane(9CI)
- 4169-27-1/octahydroquinolin-2(1H)-one
- 67133-33-9/methyl 2-(4-nitrophenyl)-2,3,3a,4-tetrahydrochromeno[4,3-b]pyrrole-3-carboxylate
- 125328-43-0/Amines, hydrogenatedrape-oil alkyl
- 107194-09-2/2-Propenoic acid, 2-methyl-, methyl ester, polymer with 1-cyclohexyl-1H-pyrrole-2,5-dione, ethenylbenzene and (1-methylethenyl)benzene
- 92797-30-3/Fatty acids, C14-22,C16-24-alkyl esters
- 54368-83-1/2-{1-[3-(1-methoxyethyl)pyridin-4-yl]ethylidene}-1,2-dihydro-3H-indol-3-one
- 93260-59-4/2-chloro-4-(2-phenylethenyl)quinoline